Provided by Tiger Trade Technology Pte. Ltd.

OptimizeRx Corporation

13.51
-0.0900-0.66%
Post-market: 13.510.00000.00%17:52 EST
Volume:402.06K
Turnover:5.44M
Market Cap:251.84M
PE:7.35K
High:13.78
Open:13.70
Low:13.25
Close:13.60
52wk High:22.25
52wk Low:3.99
Shares:18.64M
Float Shares:14.32M
Volume Ratio:1.46
T/O Rate:2.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0018
EPS(LYR):-1.0993
ROE:0.03%
ROA:2.52%
PB:2.06
PE(LYR):-12.29

Loading ...

OptimizeRx Secures Exclusive Multi-Year Partnerships to Expand Point-of-Care Network

Reuters
·
Dec 17

Halozyme Therapeutics Elects Jim Lang to Board of Directors

Reuters
·
Dec 09

OPTIMIZERx Q3 Revenue USD 26.1 Million Vs. IBES Estimate USD 23.8 Million

Reuters
·
Nov 20

OptimizeRx Unveils Presentation Showcasing Technology Solutions for Patient Engagement and Pharma Connectivity

Reuters
·
Nov 19

Stifel Nicolaus Remains a Buy on OptimizeRx (OPRX)

TIPRANKS
·
Nov 19

OptimizeRx Is Maintained at Equal-Weight by Stephens & Co.

Dow Jones
·
Nov 17

OptimizeRx Corporation Files Initial Beneficial Ownership Statement for Brendan W. Merrell, Chief Operating Officer

Reuters
·
Nov 10

OptimizeRx Q3 2025 Earnings Call Summary and Q&A Highlights: Strategic Partnerships and Predictable Revenue Model

Earnings Call
·
Nov 10

OptimizeRx (OPRX) Q3 2025 Earnings Call Transcript

Motley Fool Transcribing
·
Nov 10

OptimizeRx Down Over 17%, on Pace for Largest Percent Decrease Since November 2024 -- Data Talk

Dow Jones
·
Nov 08

OptimizeRx Is Maintained at Market Outperform by Citizens

Dow Jones
·
Nov 07

OptimizeRx reports Q3 revenue of $26.1 million, up 22% year-over-year

Reuters
·
Nov 07

BRIEF-OPTIMIZERx Q3 Revenue USD 26.1 Million Vs. IBES Estimate USD 23.8 Million

Reuters
·
Nov 07

OptimizeRx Q3 Gross Profit USD 17.5 Million

THOMSON REUTERS
·
Nov 07

OptimizeRx Corp - Introduces 2026 Revenue Guidance $118-$124 Mln

THOMSON REUTERS
·
Nov 07

OptimizeRx (OPRX) Receives a Buy from Lake Street

TIPRANKS
·
Nov 07

OptimizeRx Corp expected to post earnings of 4 cents a share - Earnings Preview

Reuters
·
Nov 05

OptimizeRx Corporation Files Initial Beneficial Ownership Statement for Chief Business Officer Andrew J. D'Silva

Reuters
·
Oct 07

Director Patrick D. Spangler Reports Disposal of Common Shares of OptimizeRx Corporation

Reuters
·
Sep 12

OptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare

Reuters
·
Aug 22